|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
NIRMATRELVIR AND RITONAVIR |
J05AE30 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005973 |
28-01-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
DE
|
POM
|
14-11-2023 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
ACICLOVIR |
J05AB01 |
DE
|
POM + Exemption
|
19-07-2023 |
DE/H/3554/001/ |
09-12-2013 |
VALID
|
|
BILASTINE |
R06AX29 |
DE
|
POM + Exemption
|
19-07-2023 |
DE/H/2300/001/DC |
08-09-2010 |
VALID
|
|
BUPRENORPHINE, COMBINATIONS |
N07BC51 |
DE
|
POM
|
19-07-2023 |
EMEA/H/C/004407 |
10-11-2017 |
VALID
|
|
SUCRALFATE |
A02BX02 |
DE
|
POM
|
19-07-2023 |
|
|
VALID
|
|
TRABECTEDIN |
L01CX01 |
DE
|
POM
|
19-07-2023 |
|
|
VALID
|
|
VARIOUS COMBINATIONS |
B03AE10 |
DE
|
Not authorised
|
19-07-2023 |
|
|
VALID
|
|
VORICONAZOLE |
J02AC03 |
DE
|
POM
|
19-07-2023 |
|
|
VALID
|
|
ZINC SULFATE |
A12CB01 |
DE
|
POM
|
19-07-2023 |
|
|
VALID
|
|
DABRAFENIB |
L01EC02 |
DE
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
FERRIC MALTOL |
B03AB10 |
DE
|
POM
|
18-07-2023 |
|
|
VALID
|
|
OSIMERTINIB |
L01EB04 |
DE
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
PEGASPARGASE |
L01XX24 |
DE
|
POM
|
18-07-2023 |
|
|
VALID
|
|
TEMSIROLIMUS |
L01EG01 |
DE
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
TRAMETINIB |
L01EE01 |
DE
|
Not authorised
|
18-07-2023 |
|
|
VALID
|
|
BOSUTINIB |
L01EA04 |
DE
|
POM
|
13-07-2023 |
|
|
VALID
|
|
EPINASTINE |
S01GX10 |
DE
|
POM
|
13-07-2023 |
|
|
VALID
|
|
NILOTINIB |
L01EA03 |
DE
|
Not authorised
|
13-07-2023 |
|
|
VALID
|
|
RAMIPRIL AND AMLODIPINE |
C09BB07 |
DE
|
POM
|
13-07-2023 |
DE/H/5074/004/ |
14-10-2015 |
VALID
|
|
BOSENTAN |
C02KX01 |
DE
|
POM
|
12-07-2023 |
DE/H/5017/002/ |
03-06-2015 |
VALID
|
|
ICATIBANT |
B06AC02 |
DE
|
POM
|
12-07-2023 |
|
01-08-2009 |
VALID
|
|
APALUTAMIDE |
L02BB05 |
DE
|
POM
|
31-05-2023 |
|
|
VALID
|
|
CEFUROXIME |
J01DC02 |
DE
|
POM
|
30-05-2023 |
DE/H/0912/002/ |
02-06-2014 |
VALID
|
|
ASCIMINIB |
L01EA06 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
CAPMATINIB |
L01EX17 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
FARICIMAB |
S01LA09 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
FOSDENOPTERIN |
A16AX19 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
INEBILIZUMAB |
L04AG10 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005818 |
25-04-2022 |
VALID
|
|
LASMIDITAN |
N02CC08 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
LENACAPAVIR |
J05AX31 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
|
LINZAGOLIX |
H01CC04 |
DE
|
POM
|
27-02-2023 |
EMEA/H/C/005442 |
14-06-2022 |
VALID
|
|
LONAFARNIB |
A16AX20 |
DE
|
POM
|
27-02-2023 |
|
|
VALID
|
